Michael W. Beaty, MD
- Associate Professor, Pathology
Michael W. Beaty, MD
- Education
- MD, Michigan State University, 1994
- Residency
- Memorial Sloan Kettering (Fellow), 1997
- AP Program, National Cancer Institute, 1998
- Fellowship
- Hematopathology, National Cancer Institute, 2000
- Board Certifications
- American Board of Pathology, Pathology-Anatomic
- American Board of Pathology, Hematology
- American Board of Pathology, Pathology-Anatomic/Pathology-Clinical
- Positions
- Associate Professor, Pathology
- Departments and Affiliations
- Pathology
Research
- PML-RARA Fusion Transcripts Detectable 8 Months prior to Promyelocytic Blast Crisis in Chronic Myeloid Leukemia. Wolanin S, McCall RK, Pettenati MJ, Beaty MW, Insuasti-Beltran G, Powell BL, O'Neill SS. . 2020; 2020:8830595.
- Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors. Wang W, Cortes JE, Lin P, Beaty MW, Ai D, Amin HM, McDonnell TJ, Ok CY, Kantarjian HM, Medeiros LJ, Hu S. Blood. 2015 Oct; 126(14):1699-706.
- Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor. Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J, Reeves-Daniel AM, Orlando G, Farney AC, Beaty MW, Pettenati MJ, Iskandar SS, Grier DD, Kaczmorski SA, Doares WH, Gautreaux MD, Freedman BI, Powell BL. . 2015; 2015:821346.
- Intracranial pseudolymphoma presenting with grand mal seizures. Strowd RE, Powers AK, Beaty MW, Ellis TL. J Clin Neurosci. 2014 May; 21(5):874-6.
- Ferritin H is a novel marker of early erythroid precursors and macrophages. Wang W, Grier DD, Woo J, Ward M, Sui G, Torti SV, Torti FM, Beaty MW. Histopathology. 2013 May; 62(6):931-40.